Humira To Compete With Remicade, Enbrel in Ankylosing Spondylitis
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approved Abbott’s adalimumab for reducing signs and symptoms in patients with active ankylosing spondylitis.